• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchImageneBio
    Picture of ImageneBio logo

    IMA — ImageneBio News Story

    $6.020.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    • Market Cap
      $67.90m
    • Enterprise Value
      -$49.31m
    • Revenue
      $0.80m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IMA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IMA Dividends
    All News

    NASDAQ RESUMED AT 03:15 PM

    Picture of ImageneBio logoImageneBio
    26/03/2021 19:15
    NASDAQ RESUMED  IKNA.O  AT 03:15 PM
    

    Recent news on ImageneBio

    See all news
    • U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

      13/04/2026 18:50
    • U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

      13/04/2026 16:43
    • Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing

      29/10/2025 13:01
    • ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview

      04/08/2025 21:54
    • Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals

      15/07/2025 21:48

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.